Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FEHCV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,642
Award facts
- Contract value 100% obligated
- $28,641.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $28,641.96 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pen injectors on September 4, 2025, with completion targeted for September 5, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen's broader federal pharmaceutical supply relationship.
This award is issued as a child contract under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive global pharmaceutical support vehicle that extends through December 2026. The prime contract enables AmerisourceBergen to supply a vast range of pharmaceutical products, medical devices, and specialized healthcare commodities to support military healthcare programs and other federal agencies including the Defense Health Agency and U.S. Coast Guard. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen maintains an extensive portfolio of delivery orders with the DLA covering diverse therapeutic domains, from specialty medications to brand-name and generic drugs, demonstrating the company's established capability to meet federal healthcare supply requirements through open competition.
Quick answers
Who was awarded contract SPE2DB25FEHCV?
SPE2DB25FEHCV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 4, 2025.
How much is contract SPE2DB25FEHCV worth?
The government has obligated $28,642 on SPE2DB25FEHCV.
Is contract SPE2DB25FEHCV an order under another contract?
Yes. SPE2DB25FEHCV is a delivery order under SPE2DB24D2205, an indefinite delivery contract.
Was contract SPE2DB25FEHCV competed?
The extent of competition for SPE2DB25FEHCV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award